NCT00451074View on ClinicalTrials.gov

Six Month Study of Gentamicin in Duchenne Muscular Dystrophy With Stop Codons

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
Duchenne Muscular Dystrophy
Interventions
DRUG

Gentamicin infusions twice a week for six months

Gentamicin infusions twice a week

Trial Locations (3)

85258

Neuromuscular Research Institute - Scottsdale Healthcare Hopsital at Shea, Scottsdale

66160-0001

University of Kansas, Kansas City

43205-2696

The Research Institute at Nationwide Children's Hospital, Columbus

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

Nationwide Children's Hospital

OTHER

NCT00451074 - Six Month Study of Gentamicin in Duchenne Muscular Dystrophy With Stop Codons | Biotech Hunter | Biotech Hunter